Harald Kramer

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population

Background and aims: This prospective trial was designed to compare the performance characteristics of five different screening tests in parallel for the detection of advanced colonic neoplasia: CT colonography (CTC), colonoscopy (OC), flexible sigmoidoscopy (FS), faecal immunochemical stool testing (FIT) and faecal occult blood testing (FOBT). Methods: Average risk adults provided stool specimens for FOBT and FIT, and underwent same-day low-dose 64-multidetector row CTC and OC using segmentally unblinded OC as the standard of reference. Sensitivities and specificities were calculated for each single test, and for combinations of FS and stool tests. CTC radiation exposure was measured, and patient comfort levels and preferences were assessed by questionnaire. Results: 221 adenomas were detected in 307 subjects who completed CTC (mean radiation dose, 4.5 mSv) and OC; 269 patients provided stool samples for both FOBT and FIT. Sensitivities of OC, CTC, FS, FIT and FOBT for advanced colonic neoplasia were 100% (95% CI 88.4% to 100%), 96.7% (82.8% to 99.9%), 83.3% (95% CI 65.3% to 94.4%), 32% (95% CI 14.9% to 53.5) and 20% (95% CI 6.8% to 40.7%), respectively. Combination of FS with FOBT or FIT led to no relevant increase in sensitivity. 12 of 45 advanced adenomas were smaller than 10 mm. 46% of patients preferred CTC and 37% preferred OC (p<0.001). Conclusions: High-resolution and low-dose CTC is feasible for colorectal cancer screening and reaches sensitivities comparable with OC for polyps >5 mm. For patients who refuse full bowel preparation and OC or CTC, FS should be preferred over stool tests. However, in cases where stool tests are performed, FIT should be recommended rather than FOBT.

Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.

The advent of positron emission tomography-computed tomography (PET-CT) and whole-body magnetic resonance imaging (WB-MRI) has introduced tumor imaging with a systemic and functional approach compared with established sequential, multimodal diagnostic algorithms. Whole-body PET with [18F]-fluoro-2-desoxy-glucose is a useful imaging procedure for tumor staging and monitoring that can visualize active tumor tissue by detecting pathological glucose metabolism. The combination of PET with the detailed anatomical information of multislice computed tomography as dual-modality scanners has markedly increased lesion localization and diagnostic accuracy compared with both modalities as standalone applications. Hardware innovations, such as the introduction of multi-receiver channel whole-body MRI scanners at 1.5 and, recently, 3 T, combined with acquisition acceleration techniques, have made high-resolution WB-MRI clinically feasible. Now, a dedicated assessment of individual organs with various soft tissue contrast, spatial resolution, and contrast media dynamics can be combined with whole-body anatomical coverage in a multiplanar imaging approach. More flexible protocols (eg, T1-weighted turbo spin-echo and short inversion recovery imaging, dedicated lung imaging or dynamic contrast-enhanced studies of the abdomen) can be performed within 45 minutes. Whole-body magnetic resonance imaging has recently been proposed for tumor screening of asymptomatic individuals, and potentially life-changing diagnoses, such as formerly unknown malignancy, have been reported. However, larger patient cohort studies will have to show the cost efficiency and the clinical effectiveness of such an approach. For initial tumor staging, PET-CT has proved more accurate for the definition of T-stage and lymph node assessment, mainly because of the missing metabolic information in WB-MRI. However, new applications, such as magnetic resonance whole-body diffusion-weighted imaging or lymphotropic contrast agents, may significantly increase sensitivity in near future. Whole-body magnetic resonance imaging has shown advantages for the detection of distant metastatic disease, especially from tumors frequently spreading to the liver or brain and as a whole-body bone marrow screening application. Within this context, WB-MRI is highly accurate for the detection of skeletal metastases and staging of multiple myeloma. This article summarizes recent developments of CT/PET-CT and WB-MRI and highlights their performance within the scope of systemic oncological imaging.

The Value of Dual-Energy Bone Removal in Maximum Intensity Projections of Lower Extremity Computed Tomography Angiography

Objective:Dual-energy computed tomography (CT) makes it possible to remove bones and intraluminal plaques from angiography datasets on the basis of spectral differentiation separating iodine from calcium. The objective of this study was to evaluate the feasibility and efficiency of this technique by comparing maximum intensity projections (MIP) created with different bone removal techniques: (a) dual-energy bone removal (DEBR); (b) purely software-based bone removal without manual corrections (SBBR − MC); and (c) manually corrected software-based bone removal (SBBR + MC). A further aim was to evaluate the dual-energy–based plaque removal tool. Materials and Methods:Fifty-one patients underwent dual-energy CT angiography of the lower-extremity arteries on a dual-source CT scanner. CT parameters were tube potentials, 140 and 80 kVp; exposure, 80 and 340 mAs/rot; and collimation, 14 × 1.2 mm. Bolus tracking was used in the descending aorta for timing (Ultravist 370). Bones were removed from the datasets using the 3 techniques and MIP datasets were generated. Two experienced radiologists assessed image quality ((1) correct removal of bones and preservation of vessels without artificial truncation, stenoses or occlusions of arteries; (2) minor errors with residual bone in the dataset or removal of side branches; (3) significant errors impeding diagnostic evaluation), number of vessel segmentation errors, and number of nonremoved bones. Additionally, time for MIP-generation was measured. The plaque removal tool was applied to DEBR MIPs and the outcome was rated as positive, neutral, or negative. Results:DEBR showed better image quality than SBBR (P < 0.05; median image quality DEBR: 1; SBBR − MC: 3; SBBR + MC: 2). Less vessel segmentation errors occurred in DEBR (P < 0.05; median DEBR: 0; SBBR − MC: 5; SBBR + MC: 1). The number of nonremoved bones was not significantly different between DEBR and SBBR + MC, but significantly higher in SBBR − MC (median DEBR: 1; SBBR − MC: 2; SBBR + MC: 0). Time for generation of MIPs was lowest for SBBR − MC (P < 0.05), but also DEBR was significantly faster than manually corrected SBBR (DEBR: 160 ± 16 seconds; SBBR − MC: 95 ± 12 seconds; SBBR + MC: 373 ± 69 seconds). The plaque removal tool lead to an improvement of image quality of the MIPs and a better depiction of the residual lumen in 43%. Conclusion:DEBR provides significant advantages, even over manually corrected SBBR. As it works completely automatically, it can effectively help to cope with the data load of CT angiography exams. Furthermore, it enables the removal of intraluminal plaques, which provides a benefit for the estimation of the residual lumen.

High-resolution magnetic resonance angiography of the lower extremities with a dedicated 36-element matrix coil at 3 Tesla

Introduction:Recent developments in hard- and software help to significantly increase image quality of magnetic resonance angiography (MRA). Parallel acquisition techniques (PAT) help to increase spatial resolution and to decrease acquisition time but also suffer from a decrease in signal-to-noise ratio (SNR). The movement to higher field strength and the use of dedicated angiography coils can further increase spatial resolution while decreasing acquisition times at the same SNR as it is known from contemporary exams. The goal of our study was to compare the image quality of MRA datasets acquired with a standard matrix coil in comparison to MRA datasets acquired with a dedicated peripheral angio matrix coil and higher factors of parallel imaging. Materials and Methods:Before the first volunteer examination, unaccelerated phantom measurements were performed with the different coils. After institutional review board approval, 15 healthy volunteers underwent MRA of the lower extremity on a 32 channel 3.0 Tesla MR System. In 5 of them MRA of the calves was performed with a PAT acceleration factor of 2 and a standard body-matrix surface coil placed at the legs. Ten volunteers underwent MRA of the calves with a dedicated 36-element angiography matrix coil: 5 with a PAT acceleration of 3 and 5 with a PAT acceleration factor of 4, respectively. The acquired volume and acquisition time was approximately the same in all examinations, only the spatial resolution was increased with the acceleration factor. The acquisition time per voxel was calculated. Image quality was rated independently by 2 readers in terms of vessel conspicuity, venous overlay, and occurrence of artifacts. The inter-reader agreement was calculated by the &kgr;-statistics. SNR and contrast-to-noise ratios from the different examinations were evaluated. Results:All 15 volunteers completed the examination, no adverse events occurred. None of the examinations showed venous overlay; 70% of the examinations showed an excellent vessel conspicuity, whereas in 50% of the examinations artifacts occurred. All of these artifacts were judged as none disturbing. Inter-reader agreement was good with &kgr; values ranging between 0.65 and 0.74. SNR and contrast-to-noise ratios did not show significant differences. Conclusion:Implementation of a dedicated coil for peripheral MRA at 3.0 Tesla helps to increase spatial resolution and to decrease acquisition time while the image quality could be kept equal. Venous overlay can be effectively avoided despite the use of high-resolution scans.

High-resolution renal MRA: comparison of image quality and vessel depiction with different parallel imaging acceleration factors.

To investigate the image quality and vessel depiction of renal MRA with integrated parallel imaging techniques (iPAT) using acceleration factors of 2 and 3.

Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography.

Purpose:The primary objective was to evaluate the prevalence of atherosclerotic disease, myocardial infarctions, and cerebrovascular disease in patients with long-standing diabetes using whole-body magnetic resonance imaging (WB-MRI) combined with whole-body magnetic resonance angiography (WB-MRA) and to estimate the cumulative disease burden in a new MRA-based score. Materials and Methods:The study was approved by the ethics committee and all patients gave informed written consent. Sixty-five patients with long-standing (>10 years) diabetes mellitus without acute symptoms were prospectively evaluated. The patients were clinically assessed and received WB-MRI/WB-MRA containing an examination of the brain, the heart, the arterial vessels (abdominal aorta, the supraaortic, renal, pelvic, and peripheral arteries), and the feet. Prevalence rates were calculated and compared with a healthy control group of 200 individuals after adjustment for age and sex by a logistic regression analysis using exact parameter estimates (Cochran-Mantel-Haenszel-statistics). Finally, an MRA based vessel score (sum of grades of all evaluated vessels divided by the number of vessels; grades range from 1, normal, to 6, complete occlusion) indicative of atherosclerotic disease burden was created for this study. This vessel scores association with clinical and biochemical parameters (age, sex, type of diabetes, diabetes duration, body mass index, blood pressure, smoking, coronary artery disease-status, retinopathy, serum creatinine, hemoglobin A1c test, low density lipoprotein-concentration, medication) was assessed with an age and sex adjusted analysis (generalized linear model). Results:In the diabetic patients, we found prevalence rates of 49% for peripheral artery disease, 25% for myocardial infarction, 28% for cerebrovascular disease, and 22% for neuropathic foot disease. In all vascular beds, at least 50% of the pathologies were previously unknown. Myocardial infarction (P= 0.0002), chronic ischemic cerebral lesions (P = 0.0008), and atherosclerotic disease were significantly more common in diabetic than in control subjects (internal carotid artery: P = 0.006, vertebral artery: P = 0.009, intracerebral vessels: P = 0.02, superficial femoral artery: P = 0.006, anterior tibial artery: P = 0.01, posterior tibial artery: P = 0.02, fibular artery: 0.003). The WB-MRI/WB-MRA-based score showed a significant association with age (P = 0.0008), male sex (P = 0.03), nephropathy (P = 0.006), diabetic retinopathy (P = 0.007), and coronary artery disease status (P = 0.006). Body mass index, blood pressure, hemoglobin A1c test, low density lipoprotein-cholesterol, and medications showed no significant association with the score. Conclusions:Using WB-MRI combined with WB-MRA we found a high prevalence of occult atherosclerotic disease in long-standing diabetic patients. This study shows that the true atherosclerotic burden in these patients is largely underestimated.

Multicenter, Double-Blind, Randomized, Intraindividual Crossover Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for MR Angiography of Peripheral Arteries

PURPOSE To prospectively compare the image quality and diagnostic performance achieved with doses of gadobenate dimeglumine and gadopentetate dimeglumine of 0.1 mmol per kilogram of body weight in patients undergoing contrast material-enhanced magnetic resonance (MR) angiography of the pelvis, thigh, and lower-leg (excluding foot) for suspected or known peripheral arterial occlusive disease. MATERIALS AND METHODS Institutional review board approval was granted from each center and informed written consent was obtained from all patients. Between November 2006 and January 2008, 96 patients (62 men, 34 women; mean age, 63.7 years +/- 10.4 [standard deviation]; range, 39-86 years) underwent two identical examinations at 1.5 T by using three-dimensional spoiled gradient-echo sequences and randomized 0.1-mmol/kg doses of each agent. Images were evaluated on-site for technical adequacy and quality of vessel visualization and offsite by three independent blinded readers for anatomic delineation and detection/exclusion of pathologic features. Comparative diagnostic performance was determined in 31 patients who underwent digital subtraction angiography. Data were analyzed by using the Wilcoxon signed-rank, McNemar, and Wald tests. Interreader agreement was determined by using generalized kappa statistics. Differences in quantitative contrast enhancement were assessed and a safety evaluation was performed. RESULTS Ninety-two patients received both agents. Significantly better performance (P < .0001; all evaluations) with gadobenate dimeglumine was noted on-site for technical adequacy and vessel visualization quality and offsite for anatomic delineation and detection/exclusion of pathologic features. Contrast enhancement (P < or = .0001) and detection of clinically relevant disease (P < or = .0028) were significantly improved with gadobenate dimeglumine. Interreader agreement for stenosis detection and grading was good to excellent (kappa = 0.749 and 0.805, respectively). Mild adverse events were reported for four (six events) and five (eight events) patients after gadobenate dimeglumine and gadopentetate dimeglumine, respectively. CONCLUSION Higher-quality vessel visualization, greater contrast enhancement, fewer technical failures, and improved diagnostic performance are obtained with gadobenate dimeglumine, relative to gadopentetate dimeglumine, when compared intraindividually at 0.1-mmol/kg doses in patients undergoing contrast-enhanced MR angiography for suspected peripheral arterial occlusive disease.

Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation.

Introduction:To investigate the feasibility and image quality of gadofosveset-enhanced steady-state peripheral MR-angiography using Dixon fat saturation in comparison to spectral fat saturation. Materials and Methods:After Institutional Review Board (IRB) approval, 10 healthy volunteers underwent peripheral MR-angiography at 3.0 T during the steady state 50 minutes after gadofosveset injection. A steady-state-adapted volume interpolated breathhold examination sequence with an isotropic spatial resolution of 1 mm was acquired with 2-point Dixon fat saturation (DixFS, acquisition time 52 seconds) and with conventional, spectral fat saturation (SFS, acquisition time 58 seconds). The quality of the images was rated on an ordinal 4-point scale (4, very good) by 2 radiologists in consensus. The signal-to-noise ratios (SNRs) of the vessels, the fat, and the muscles as well as the contrast-to-noise-ratio (CNR) between vessels, fat, and muscle were determined. Paired P tests were performed for statistical analysis with a significance level of P < 0.05. Results:Diagnostic image quality was achieved in all examinations. The image quality of the DixFS images was rated superior (median 4) over the SFS images (median 3; P = 0.03). The SNR of muscles and vessels was 40% higher with DixFS (P < 0.008), whereas the SNR of fat was decreased by 40.3% from 40.7 with SFS to 22.4 with DixFS (P < 0.0001). The CNR (fat/muscle) of the DixFS images of 84.1/71.7 was significantly higher than the CNR of the SFS images of 47.7/47.4 (P < 0.001). Discussion:Two-point Dixon fat suppression for MR-angiography during the steady state after the administration of gadofosveset is feasible with superior image quality and more than 50% increase in CNR (fat/muscle) compared with spectral fat saturation without an additional time penalty.

Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

Emerging magnetic resonance imaging (MRI) biomarkers of hepatic steatosis have demonstrated tremendous promise for accurate quantification of hepatic triglyceride concentration. These methods quantify the proton density fat‐fraction (PDFF), which reflects the concentration of triglycerides in tissue. Previous in vivo studies have compared MRI‐PDFF with histologic steatosis grading for assessment of hepatic steatosis. However, the correlation of MRI‐PDFF with the underlying hepatic triglyceride content remained unknown. The aim of this ex vivo study was to validate the accuracy of MRI‐PDFF as an imaging biomarker of hepatic steatosis. Using ex vivo human livers, we compared MRI‐PDFF with magnetic resonance spectroscopy‐PDFF (MRS‐PDFF), biochemical triglyceride extraction, and histology as three independent reference standards. A secondary aim was to compare the precision of MRI‐PDFF relative to biopsy for the quantification of hepatic steatosis. MRI‐PDFF was prospectively performed at 1.5 Tesla in 13 explanted human livers. We performed colocalized paired evaluation of liver fat content in all nine Couinaud segments using single‐voxel MRS‐PDFF (n = 117) and tissue wedges for biochemical triglyceride extraction (n = 117), and five core biopsies performed in each segment for histologic grading (n = 585). Accuracy of MRI‐PDFF was assessed through linear regression with MRS‐PDFF, triglyceride extraction, and histology. Intraobserver agreement, interobserver agreement, and repeatability of MRI‐PDFF and histologic grading were assessed through Bland‐Altman analyses. MRI‐PDFF showed an excellent correlation with MRS‐PDFF (r = 0.984, confidence interval 0.978‐0.989) and strong correlation with histology (r = 0.850, confidence interval 0.791‐0.894) and triglyceride extraction (r = 0.871, confidence interval 0.818‐0.909). Intraobserver agreement, interobserver agreement, and repeatability showed a significantly smaller variance for MRI‐PDFF than for histologic steatosis grading (all P < 0.001). Conclusion: MRI‐PDFF is an accurate, precise, and reader‐independent noninvasive imaging biomarker of liver triglyceride content, capable of steatosis quantification over the entire liver. (Hepatology 2015;62:1444–1455)

Intraindividual comparison of MR-renal perfusion imaging at 1.5 T and 3.0 T.

Purpose:The purpose of this study was to intraindividually compare fast gradient-echo semiquantitative renal perfusion measurements at 1.5 Tesla (T) and 3.0 Tesla. Materials and Methods:Fifteen healthy male volunteers underwent renal perfusion measurements at 1.5 T and 3.0 T after the bolus injection of 7 mL of Gd-BOPTA. At both field strengths a Saturation-Recovery-fast gradient echo sequence (SR-TurboFLASH) with a temporal resolution of 4 (1.5 T) and 5 (3.0 T) simultaneously acquired slices per second was used. At 3.0 T, a parallel-imaging factor 2 was applied. For postprocessing, semiquantitative perfusion parameters including mean transit time (MTT), time to peak (TTP), and maximal signal intensity (SMax) were determined. The signal-to-noise ratios (SNR) of kidneys and aorta were determined precontrast and after enhancement. The image quality was rated by 2 radiologists. After Bonferroni correction paired t-tests were performed for statistical analysis. Results:All measurements were successfully performed. At 3.0 T, a significant 63% increase in the baseline SNR (P = 0.00005) of the kidneys was found, the peak SNR was also increased though not statistically significant. Because of the higher SNR, the SMax was also significantly (P = 0.005) increased from 406 A.U. to 522 A.U., whereas MTT and TTP were not significantly changed. The image quality was rated very good to good for the 3.0 T images but only good to moderate at 1.5 T. Conclusion:Renal perfusion measurements at 3.0 T are feasible and directly benefit from the inherently higher SNR at 3.0 T. The higher SNR also translates into an increased SMax, whereas MTT and TTP are independent of the field strength.